These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 14718437

  • 1. Pulmonary nodules in lung transplant recipients: etiology and outcome.
    Lee P, Minai OA, Mehta AC, DeCamp MM, Murthy S.
    Chest; 2004 Jan; 125(1):165-72. PubMed ID: 14718437
    [Abstract] [Full Text] [Related]

  • 2. The pulmonary nodule after lung transplantation. Cause and outcome.
    End A, Helbich T, Wisser W, Dekan G, Klepetko W.
    Chest; 1995 May; 107(5):1317-22. PubMed ID: 7750325
    [Abstract] [Full Text] [Related]

  • 3. Posttransplant lymphoproliferative disorders in lung transplant recipients: clinical experience at a single center.
    Angel LF, Cai TH, Sako EY, Levine SM.
    Ann Transplant; 2000 May; 5(3):26-30. PubMed ID: 11147026
    [Abstract] [Full Text] [Related]

  • 4. Bronchogenic carcinoma and secondary aspergillosis--common yet unexplored: evaluation of the role of bronchoalveolar lavage-polymerase chain reaction and some nonvalidated serologic methods to establish early diagnosis.
    Shahid M, Malik A, Bhargava R.
    Cancer; 2008 Aug 01; 113(3):547-58. PubMed ID: 18521930
    [Abstract] [Full Text] [Related]

  • 5. Post-transplantation lymphoproliferative disorder in heart and kidney transplant patients: a single-center experience.
    Wasson S, Zafar MN, Best J, Reddy HK.
    J Cardiovasc Pharmacol Ther; 2006 Mar 01; 11(1):77-83. PubMed ID: 16703222
    [Abstract] [Full Text] [Related]

  • 6. Clinical and radiologic factors associated with pulmonary nodule etiology in organ transplant recipients.
    Copp DH, Godwin JD, Kirby KA, Limaye AP.
    Am J Transplant; 2006 Nov 01; 6(11):2759-64. PubMed ID: 17049063
    [Abstract] [Full Text] [Related]

  • 7. Posttransplant lymphoproliferative disorder: incidence, presentation, and response to treatment in lung transplant recipients.
    Reams BD, McAdams HP, Howell DN, Steele MP, Davis RD, Palmer SM.
    Chest; 2003 Oct 01; 124(4):1242-9. PubMed ID: 14555552
    [Abstract] [Full Text] [Related]

  • 8. Posttransplantation lymphoproliferative disorder: manifestations in pediatric thoracic organ recipients.
    Lim GY, Newman B, Kurland G, Webber SA.
    Radiology; 2002 Mar 01; 222(3):699-708. PubMed ID: 11867788
    [Abstract] [Full Text] [Related]

  • 9. Invasive pulmonary aspergillosis following bone marrow transplantation: risk factors and diagnostic aspect.
    Soubani AO, Qureshi MA.
    Haematologia (Budap); 2002 Mar 01; 32(4):427-37. PubMed ID: 12803117
    [Abstract] [Full Text] [Related]

  • 10. Lung nodules and masses after cardiac transplantation.
    Haramati LB, Schulman LL, Austin JH.
    Radiology; 1993 Aug 01; 188(2):491-7. PubMed ID: 8327703
    [Abstract] [Full Text] [Related]

  • 11. A low incidence of posttransplant lymphoproliferative disorder in 109 lung transplant recipients.
    Levine SM, Angel L, Anzueto A, Susanto I, Peters JI, Sako EY, Bryan CL.
    Chest; 1999 Nov 01; 116(5):1273-7. PubMed ID: 10559086
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Lung retransplantation after posttransplantation lymphoproliferative disorder (PTLD): a single-center experience and review of literature of PTLD in lung transplant recipients.
    Raj R, Frost AE.
    J Heart Lung Transplant; 2005 Jun 01; 24(6):671-9. PubMed ID: 15949726
    [Abstract] [Full Text] [Related]

  • 16. Thoracic presentations of posttransplant lymphoproliferative disorders.
    Halkos ME, Miller JI, Mann KP, Miller DL, Gal AA.
    Chest; 2004 Dec 01; 126(6):2013-20. PubMed ID: 15596707
    [Abstract] [Full Text] [Related]

  • 17. Abdominal involvement in pediatric heart and lung transplant recipients with posttransplant lymphoproliferative disease increases the risk of mortality.
    Tai CC, Curtis JL, Szmuszkovicz JR, Horn MV, Ford HR, Woo MS, Wang KS.
    J Pediatr Surg; 2008 Dec 01; 43(12):2174-7. PubMed ID: 19040929
    [Abstract] [Full Text] [Related]

  • 18. CT-guided percutaneous lung biopsies in patients with haematologic malignancies and undiagnosed pulmonary lesions.
    Gupta S, Sultenfuss M, Romaguera JE, Ensor J, Krishnamurthy S, Wallace MJ, Ahrar K, Madoff DC, Murthy R, Hicks ME.
    Hematol Oncol; 2010 Jun 01; 28(2):75-81. PubMed ID: 19728397
    [Abstract] [Full Text] [Related]

  • 19. Primary central nervous system posttransplantation lymphoproliferative disorder after heart and lung transplantation.
    Gifford G, Fay K, Jabbour A, Ma DD.
    Intern Med J; 2015 May 01; 45(5):583-6. PubMed ID: 25955465
    [Abstract] [Full Text] [Related]

  • 20. Posttransplantation lymphoproliferative disorder in lung transplant recipients: a 15-year single institution experience.
    Muchtar E, Kramer MR, Vidal L, Ram R, Gurion R, Rosenblat Y, Bakal I, Shpilberg O.
    Transplantation; 2013 Oct 15; 96(7):657-63. PubMed ID: 23823652
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.